Navigation Links
How major signaling pathways are wired to our genome gives new insight into disease processes
Date:10/27/2011

scription factors.

The discovery sheds new light on the relationship between signaling pathways, gene expression, cell function, and diseaseat the same time revealing potential targets for therapeutic intervention and novel approaches for reprogramming neurons or insulin-producing beta cells to treat nerve damage or diabetes.

"This is a broad, simplifying concept that is key to understanding how the whole human system works and how the genome responds to the world around itthat each signaling pathway has its own signaling molecule that finds its way to that cell's type-specific master transcription factor," says Young, who is also a professor of biology at MIT. "This idea allows us to think clearly about what is going awry in disease and how we potentially can treat people by modifying these signaling pathways."

To tease apart how signaling pathways modulate gene expression, Alan Mullen, who is the Cell paper's first author and a visiting scientist in the Young lab, analyzed the transforming growth factor-beta (TGF-beta) signaling pathway in several types of mouse and human cells. In both developing and mature cells, the TGF-beta pathway is involved in numerous cell activities, including specialization, homeostasis, and programmed death. Yet, corrupted versions of the TGF-beta signaling pathway are frequently found in cancer cells, allowing the cancer cells to proliferate and escape normal programmed cell death.

Mullen knew that when the TGF-beta signaling pathway's receptor is triggered by an environmental change, it activates the SMAD3 protein, which somehow couriers the receptor's message to the cell's DNA. Previous research had also suggested that SMAD3 might interact with hundreds of different transcription factors to achieve the desired response to environmental input.

Looking at embryonic stem, muscle, and certain immune system cells, Mullen found that once inside the nucleus, the activated SMAD3 settles ont
'/>"/>

Contact: Nicole Giese
giese@wi.mit.edu
617-258-6851
Whitehead Institute for Biomedical Research
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Policymakers should prepare for major uncertainties with Medicaid expansion
2. Ghost Writing Persists in Major Medical Journals
3. Teenage girls and senior students suffered highest levels of PTSD after major earthquake
4. Harvard Medical School launches major initiative to address crisis in drug development
5. Alcohol, Obesity Major Causes of Sudden Heart Death
6. Prevention measures needed to address major risk of falls after stroke
7. Major HIV prevention trial in women to drop oral tenofovir arm
8. Major grant awarded for HIV prevention study in Africa
9. Researchers find process that clears cholesterol and could reverse major cause of heart attack
10. Major ALS breakthrough
11. Major advanced cancer study to be led by Uppsala University
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... who show signs of chronic inflammation in non-cancerous prostate ... having prostate cancer than those with no inflammation, according ... from the Johns Hopkins Kimmel Cancer Center. , The ... for men with so-called high-grade prostate cancer those ... indicating the presence of the most aggressive and rapidly ...
(Date:4/17/2014)... One of the most popular vaccine brands for ... doctors may be overlooking some cost factors when choosing ... more expensive option, according to a new study by ... to administer can be driven by numerous factors," says ... a professor of computer science and of mathematics at ...
(Date:4/17/2014)... San Diego School of Medicine report that older women, ... major loss are more likely to be compassionate toward ... published in this month,s issue of the International ... are associated with better health and well-being as we ... improve the outcomes of individuals whose deficits in compassion ...
(Date:4/17/2014)... Le Bonheur Children,s Hospital Pediatrician-in-Chief Jon McCullers, MD, ... the April issue of Nature Reviews Microbiology ... Dr. McCullers, a world-renowned infectious disease specialist, ... the University of Tennessee Health Science Center, analyzed ... 1918, 1957 and 1968 pandemics, as well as ...
(Date:4/17/2014)... Doctors who treat patients with a severe ... face an agonizing treatment decision. , The drug ... help relieve shortness of breath. But some patients ... cause potentially fatal complications following transplantation. , "It,s ... medical director of Loyola University Medical Center,s LAM ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study recalculates costs of combination vaccines 2Health News:The ilk of human kindness 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3
... University School of Medicine in St. Louis working with ... cells long thought to be responsible for type 1 ... immune cells from isolated insulin-making structures in the pancreas ... immune cells, known as dendritic cells, "red-handed": carrying insulin ...
... Retired Air Force,Colonel Mike Turner, a Democratic candidate for ... Care Countdown" inspired by MSNBC host,Keith Olbermann. Today is ... and a key architect of Hillary Clinton,s,notorious 1993 health ... to tell 10th District voters what, if any, plan ...
... Aid through Dubai Cares, DUBAI, United Arab Emirates, ... Maktoum, Vice President and Prime Minister of the,U.A.E. and ... structures to be used as schools and shelter to ... donation. The,official death toll currently stands at 22,000, with ...
... Calif., May 9 Dakim, Inc., announced,today that ... in,health and fitness, has signed on as a ... [m]Power Cognitive Fitness System, joining the,company,s efforts to ... is a touch screen-based brain workout program designed,to ...
... 9 Roche announced today that Sarah,Vidal, M.P.H., ... as a 2008 Rising Star by the Healthcare ... on May 8,2008 in New York City., ... combination of,confidence, energy, experience, contagious enthusiasm and respect ...
... to provide more visible presence for world,s largest surgical,organization, ... (ACS) today broke ground for a new home for ... presence on Capitol Hill. The,10-story, class A office building, ... the first quarter of 2010. ACS headquarters will remain ...
Cached Medicine News:Health News:Suspected cause of type 1 diabetes caught 'red-handed' for the first time 2Health News:Suspected cause of type 1 diabetes caught 'red-handed' for the first time 3Health News:Mike Turner, Virginia Congressional Candidate, Starts Healthcare Countdown 2Health News:Dubai Provides Aid for Cyclone Nargis Victims In Myanmar 2Health News:Physical Fitness 'Godfather' Jack LaLanne Turns to Brain Fitness, Becoming Ambassador for Dakim's [m]Power System 2Health News:Roche's Vidal Honored as 2008 HBA Rising Star 2Health News:American College of Surgeons Breaks Ground on New Office Building on Capitol Hill 2
(Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ...
(Date:1/14/2014)... , Jan. 14, 2014 HeartWare International, ... innovator of less invasive, miniaturized circulatory support technologies that ... announced that it expects revenues for the fourth quarter ... full-year 2013 revenues to approximately $208 million. ...
(Date:1/14/2014)... North America,s leading business partnering event ... 30 th edition of its annual conference at the ... 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... specialty chemical companies will take part in the conference, which ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
... useful and focused trial that builds on the body ... possible care for diabetic patients with chronic stable angina ... for Cardiovascular Angiography and Interventions (SCAI) encourages healthcare providers ... their patients, as studied in this trial. BARI-2D ...
... 69th Annual ADA Scientific Sessions Examined Efficacy and Safety ... , NEW ORLEANS, June 6 /PRNewswire-FirstCall/ -- ... "Effects of 1, 2, or 3 Prandial Injections of ... Patients on Insulin Glargine and Oral Drugs," evaluating patients ...
Cached Medicine Technology:SCAI Statement on the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation With Diabetes Trial) Presented at the American Diabetes Association (ADA) Annual Scientific Sessions and Published in The New England Journal of Medicine 2SCAI Statement on the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation With Diabetes Trial) Presented at the American Diabetes Association (ADA) Annual Scientific Sessions and Published in The New England Journal of Medicine 3SCAI Statement on the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation With Diabetes Trial) Presented at the American Diabetes Association (ADA) Annual Scientific Sessions and Published in The New England Journal of Medicine 4New Study Showed Lantus(R) Plus One, Two or Three Shots of Apidra(R) Lowered Patients' Blood Sugar 2New Study Showed Lantus(R) Plus One, Two or Three Shots of Apidra(R) Lowered Patients' Blood Sugar 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: